We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+1.87%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$763M
AUM Growth
+$25.6M
Cap. Flow
+$12.4M
Cap. Flow %
1.62%
Top 10 Hldgs %
60.2%
Holding
534
New
65
Increased
123
Reduced
59
Closed
32

Top Buys

Rank Stock Value
1
VGIT icon
Vanguard Intermediate-Term Treasury ETF
VGIT
+$3.54M
2
NVDA icon
NVIDIA
NVDA
+$2.12M
3
VNQ icon
Vanguard Real Estate ETF
VNQ
+$1.03M
4
VIGI icon
Vanguard International Dividend Appreciation ETF
VIGI
+$987K
5
VGSH icon
Vanguard Short-Term Treasury ETF
VGSH
+$801K

Top Sells

Rank Stock Value
1
SPTM icon
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
+$4.26M
2
IBDQ
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
+$983K
3
SCHF icon
Schwab International Equity ETF
SCHF
+$556K
4
VV icon
Vanguard Morningstar Large-Cap ETF
VV
+$367K
5
SCHB icon
Schwab US Broad Market ETF
SCHB
+$352K

Sector Composition

Rank Sector Weight
1 Technology 1.73%
2 Financials 1.46%
3 Consumer Discretionary 0.93%
4 Healthcare 0.45%
5 Industrials 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLX icon
151
Clorox
CLX
$12.7B
$129K 0.02%
1,275
+508
+66% +$55.2K
TEL icon
152
TE Connectivity
TEL
$62.6B
$129K 0.02%
+569
New +$132K
TSM icon
153
TSMC
TSM
$2.18T
$129K 0.02%
423
+2
+0.5% +$587
UNP icon
154
Union Pacific
UNP
$174B
$126K 0.02%
546
+333
+156% +$76K
VRTX icon
155
Vertex Pharmaceuticals
VRTX
$126B
$126K 0.02%
279
– –
IBDY icon
156
iShares iBonds Dec 2033 Term Corporate ETF
IBDY
$1.09B
$125K 0.02%
+4,786
New +$125K
VUG icon
157
Vanguard Morningstar Growth ETF
VUG
$231B
$122K 0.02%
1,506
– –
IAU icon
158
iShares Gold Trust
IAU
$67.5B
$121K 0.02%
1,493
– –
AXON
159
Axon Enterprise
AXON
$46.4B
$116K 0.02%
204
– –
SRE icon
160
Sempra
SRE
$54.8B
$116K 0.02%
1,316
– –
VZ icon
161
Verizon
VZ
$196B
$115K 0.02%
2,834
+964
+52% +$39.1K
MET icon
162
MetLife
MET
$62.4B
$113K 0.01%
1,430
– –
GRAL
163
GRAIL Inc
GRAL
$2.98B
$113K 0.01%
1,324
– –
MFEM icon
164
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF
MFEM
$148M
$111K 0.01%
+4,799
New +$109K
COST icon
165
Costco
COST
$420B
$106K 0.01%
123
– –
SCHW
166
Charles Schwab
SCHW
$187B
$104K 0.01%
+1,037
New +$98.4K
WMT icon
167
Walmart Inc
WMT
$890B
$103K 0.01%
926
+604
+188% +$64.9K
NUE icon
168
Nucor
NUE
$62.1B
$102K 0.01%
624
+2
+0.3% +$301
SO icon
169
Southern Company
SO
$107B
$101K 0.01%
1,154
– –
ED icon
170
Consolidated Edison
ED
$39.8B
$99K 0.01%
1,000
– –
CB icon
171
Chubb
CB
$135B
$97K 0.01%
310
+266
+605% +$77.8K
MMM icon
172
3M
MMM
$94.3B
$96K 0.01%
+602
New +$98.4K
V icon
173
Visa
V
$677B
$94K 0.01%
269
-69
-20% -$23.5K
PFE icon
174
Pfizer
PFE
$153B
$91K 0.01%
3,656
-505
-12% -$12.7K
T icon
175
AT&T
T
$163B
$91K 0.01%
3,654
-266
-7% -$6.73K
5 6
7
8 9

Similar funds

ICM
Innovator Capital Management Wheaton, Illinois $925M AUM 49.11% 1-Year Est. Return
TC
Tairen Capital Hong Kong $924M AUM 105.21% 1-Year Est. Return
CFA
Cahill Financial Advisors Edina, Minnesota $924M AUM 16.55% 1-Year Est. Return
GFG
Goldstone Financial Group Oakbrook Terrace, Illinois $922M AUM 14.34% 1-Year Est. Return
KI
Koch Inc Wichita, Kansas $922M AUM 16.65% 1-Year Est. Return
WC
Westerkirk Capital Victoria $929M AUM 21.93% 1-Year Est. Return
BCC
Biglari Capital Corp San Antonio, Texas $929M AUM 39.8% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return

Roble Belko & Company's Q4 2025 Portfolio in Review

As of Q4 2025, Roble Belko & Company held 534 positions worth $763M, up 3.5% from $738M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Roble Belko & Company's Q4 2025 filing shows 65 new, 123 increased, 59 reduced and 32 closed positions. Its largest new stake was Akre Focus ETF: 8,392 shares worth $550K. The largest sale was State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF, an estimated $4.26M.

By sector, the portfolio is most concentrated in Technology at 1.7% of assets, up from 1.4% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Roble Belko & Company's largest Q4 2025 buy was Akre Focus ETF: 8,392 shares worth $550K.
  • Roble Belko & Company added most to Vanguard Intermediate-Term Treasury ETF in Q4 2025, an estimated $3.54M increase.
  • Roble Belko & Company's biggest Q4 2025 reduction was State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF, cutting an estimated $4.26M.
  • Roble Belko & Company fully exited iShares iBonds Dec 2025 Term Corporate ETF in Q4 2025, selling an estimated $983K.
  • Roble Belko & Company's ten largest holdings make up 60% of its $763M portfolio in Q4 2025.
  • Roble Belko & Company opened 65 new positions and closed 32 in Q4 2025.
  • Roble Belko & Company's portfolio value rose 3.5% quarter-over-quarter to $763M.

Based on Roble Belko & Company's 13F filing for Q4 2025, filed 12 Jan 2026.